09 Feb 2026 | 3 Mins Read
Zydus Lifesciences makes four global acquisitions in a year
Flipitmoney
Zydus Lifesciences expands globally through selective acquisitions in biologics, MedTech, and specialty pharma. The company made 4 international acquisitions in a year with a ₹88,297 crore market cap and achieved 118.8% five-year returns, shifting focus beyond US generics and expanding its presence in international healthcare markets.